The Monoclonal Antibodies That Could Treat Hepatocellular Carcinoma
AndCan / Pixabay

The Monoclonal Antibodies That Could Treat Hepatocellular Carcinoma

Hepatocellular carcinoma is a form of cancer that starts out in the liver. As far as cancers that begin in the liver, it's common, but it's still important to differentiate it…

Continue Reading The Monoclonal Antibodies That Could Treat Hepatocellular Carcinoma
University of Pittsburgh Joins Centers Researching Early Detection of Pancreatic Cancer
Source: Pixabay

University of Pittsburgh Joins Centers Researching Early Detection of Pancreatic Cancer

Pancreatic cancer is rare, and often, patients don't show symptoms until they're already in the later stages. Top pancreatic cancer centers in the country have been working together to find…

Continue Reading University of Pittsburgh Joins Centers Researching Early Detection of Pancreatic Cancer
Cannabidiol Oral Solution Granted Fast Track Application for Prader-Willi Syndrome
Source: Pixabay

Cannabidiol Oral Solution Granted Fast Track Application for Prader-Willi Syndrome

Prader-Willi syndrome is a rare condition which causes the body to feel insatiable hunger, regardless of how much a patient eats. Treatment options are currently inadequate for many patients. Today,…

Continue Reading Cannabidiol Oral Solution Granted Fast Track Application for Prader-Willi Syndrome
Texas Family is Racing to Raise $100k to Benefit Their Son Who Suffers From Hereditary Spastic Parapalegia
Source: Pixabay

Texas Family is Racing to Raise $100k to Benefit Their Son Who Suffers From Hereditary Spastic Parapalegia

Originally reported by KVUE ABC, the race is on for the Rosenberg family to raise the funds that will benefit their 3-year-old child suffering from a rare brain disease known…

Continue Reading Texas Family is Racing to Raise $100k to Benefit Their Son Who Suffers From Hereditary Spastic Parapalegia
Recent Study Results Reveal New Possibilities in Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)
PNH causes the immune system to destroy red blood cells. Source: pixabay.com

Recent Study Results Reveal New Possibilities in Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)

On December 11, Alexion Pharmaceuticals, Inc. released dose-ranging data from a recent clinical study involving treatment with ALXN1210, which is an investigational long-acting C5 complement inhibitor meant to treat sufferers…

Continue Reading Recent Study Results Reveal New Possibilities in Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)
Close Menu